The Pure-Play Pot Stock Index Finally Went Down On Tuesday

The munKNEE Pure-Play* Pot Stock Index went down 1.2% on Tuesday after increases of 4.4%, 2.4%, 9.3%, and 4.7% the previous four trading days. 13 of the 25 constituents went down and 12 went up. All 3 of the industry categories went down. Details are as follows:

Index Performance

The Index has companies doing business in a number of different categories and sub-categories based on their primary area of focus in the cannabis industry. These categories are identified below along with those pure-play stocks within each category that went up or down by 5% or more:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 22 index constituents that grow, process, and sell cannabis and hemp flower and related products and it was down 1.1%.
   1. the Canadian Licensed Producer (LPs) has 7 index constituents and it went down 3.8%, on average, but only one stock changed price by 5% or more, namely, Tilray (TLRY) which went down 5.9%.
   2. the U.S. Multi-State Operator (MSOs) Category has 13 index constituents and it went down 0.5%, on average, but no stock within the category changed price by 5% or more.
   3. The hemp seed-to-sale MSO sub-category has two index constituents and it went up 4.3%, on average, but only one stock changed price by 5% or more, namely Charlotte's Web (CWBHF) which went down 7.1%.
2. The Extraction Category has two index constituents focused on the extraction of cannabis compounds and their infusion into consumer products and it went down 4.8%, on average, with only one stock changing price by 5% or more, namely Valens (VLNCF) which went down 6.9%.
3. The Consumption Devices Category has only one index constituent focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers, namely, Greenlane (GNLN), and it went down 1.3%.

*Please note: Each of the 25 pure-play stocks in the munKNEE.com Pure-Play Pot Stock Index are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, the Index reflects the true health of the marijuana industry in the U.S. and Canada. In addition, the Index only includes those pure-play cannabis stocks that consistently trade for more than US$1/share.